申请人:Ribon Therapeutics Inc.
公开号:US10562891B2
公开(公告)日:2020-02-18
The present invention relates to quinazolinones and related compounds which are inhibitors of PARP14 and are useful, for example, in the treatment of cancer and inflammatory diseases.
本发明涉及
喹唑啉酮类及相关化合物,它们是 PARP14 的
抑制剂,可用于治疗癌症和炎症等疾病。